474686-34-5

Upstream product

• 2212-75-1 N₂-[(benzyloxy)carbonyl]-L-lysine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 2389-60-8 Z-Lys(Boc)-OH 
• 5619-04-5 methyl 2-amino-3-hydroxypropanoate hydrochloride 

Downstream Products

• 956111-87-8 C₂₃H₃₃N₃O₇ 
• 474686-33-4 2-(1-benzyloxycarbonylamino-5-tert-butoxycarbonylamino-pentyl)-oxazole-4-carboxylic acid methyl ester 
• 956111-91-4 C₂₉H₃₃N₅O₉ 
• 956111-89-0 C₂₉H₃₇N₅O₁₀ 
• 956111-88-9 C₃₈H₅₇N₅O₁₀Si 
• 1111629-64-1 C₂₉H₃₅N₅O₉ 
• 474686-23-2 2-(1-benzyloxycarbonylamino-5-tert-butoxycarbonylamino-pentyl)-oxazole-4-carboxylic acid 

Relevant academic research and scientific papers

THERAPEUTIC COMPOUNDS

The invention provides compounds of formula I: wherein A, B, D, E, R1, R2, R3, R4, R5, X, and ----- have any values defined herein, as well as salts thereof. The compounds have activity as G-quadruplex DNA stabilizers and as anti-proliferative agents.

THERAPEUTIC COMPOUNDS

The invention provides compounds of formula (I) wherein A, B, R1, F, G, n, n' and the dotted line have any values defined herein, as well as salts thereof. The compounds have activity as anti-proliferative agents.

THERAPEUTIC COMPOUNDS

The invention provides compounds of formula I: wherein A, B, D, E, R1, R2, R3, R4, R5, X, and ----- have any values defined herein, as well as salts thereof. The compounds have activity as G-quadruplex DNA stabalizers and as anti-proliferative agents.